NCT07025915View on ClinicalTrials.gov

A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Healthy Subjects (HS)

Interventions

DRUG

[14C]SSS17

single oral dose

All Listed Sponsors

lead

Shenyang Sunshine Pharmaceutical Co., LTD.

INDUSTRY